TABLE 2.
No. of Patients (%) |
||||
---|---|---|---|---|
Nodal Management |
Adjuvant Systemic Therapya |
|||
Site of Recurrence | Dissection, N = 189 | Surveillance, N = 965 | Yes, N = 439 | No, N = 712 |
No recurrence | 148 (78) | 786 (81) | 358 (82) | 573 (80) |
Recurrence | 41 (22) | 179 (19) | 81 (18) | 139 (20) |
Local-regional onlyb | 11 (6) | 40 (4) | 19 (4) | 32 (5) |
SLN basin only | 7 (4) | 61 (6) | 24 (5) | 44 (6) |
Distant only | 16 (8) | 41 (4) | 21 (5) | 36 (5) |
Multiple sites | 7 (4) | 37 (4) | 17 (4) | 27 (4) |
Including nodal | 4 (2) | 35 (4) | 14 (3) | 24 (3) |
Not including nodal | 3 (2) | 2 (<1) | 3 (1) | 3 (1) |
Abbreviation: SLN, sentinel lymph node.
Data regarding adjuvant therapy were not available for 3 participants.
Local-regional includes the primary site and in-transit disease.